UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTY
3976
Getty Realty Corp
GTY
$2B
| $1.61M | ﹤0.01% |
60,390
-5,210
| -8% | -$142K |
|
3977
Corporacion America
CAAP
$4.11B
| $1.61M | ﹤0.01% |
96,557
+62,691
| +185% | +$1.09M |
|
3978
Stock Yards Bancorp
SYBT
$2.59B
| $1.6M | ﹤0.01% |
32,311
-9,304
| -22% | -$434K |
|
|
HI
3979
DELISTED
Hillenbrand
HI
| $1.6M | ﹤0.01% |
40,093
-44,224
| -52% | -$1.99M |
|
|
BRFS
3980
DELISTED
BRF SA
BRFS
| $1.6M | ﹤0.01% |
393,838
+341,638
| +654% | +$1.2M |
|
3981
Powell Industries
POWL
$7.73B
| $1.6M | ﹤0.01% |
33,486
+8,358
| +33% | +$436K |
|
3982
Editas Medicine
EDIT
$444M
| $1.6M | ﹤0.01% |
342,121
-253,844
| -43% | -$1.43M |
|
3983
Stoke Therapeutics
STOK
$2.05B
| $1.6M | ﹤0.01% |
118,254
+78,839
| +200% | +$1.06M |
|
3984
CALL
Novartis
NVS
$299B
| $1.6M | ﹤0.01% |
+15,000
| New | +$1.51M |
|
|
ZK
3985
DELISTED
Zeekr
ZK
| $1.6M | ﹤0.01% |
+84,761
| New | +$2.03M |
|
3986
PUT
C3.ai
AI
$1.6B
| $1.59M | ﹤0.01% |
+55,000
| New | +$1.41M |
|
3987
PUT
Freshpet
FRPT
$3.35B
| $1.59M | ﹤0.01% |
12,300
| – | – |
|
3988
CALL
Teck Resources
TECK
$33B
| $1.59M | ﹤0.01% |
33,200
-310,056
| -90% | -$15.3M |
|
3989
Pediatrix Medical
MD
$2.14B
| $1.59M | ﹤0.01% |
210,461
+119,229
| +131% | +$986K |
|
3990
UWM Holdings
UWMC
$2.34B
| $1.59M | ﹤0.01% |
229,000
-112,304
| -33% | -$772K |
|
3991
Avantis International Small Cap Value ETF
AVDV
$19.8B
| $1.58M | ﹤0.01% |
24,375
+4,557
| +23% | +$301K |
|
|
SFIX
3992
Stitch Fix
SFIX
$514M
| $1.58M | ﹤0.01% |
381,238
-107,932
| -22% | -$292K |
|
3993
PUT
iQIYI
IQ
$1.3B
| $1.58M | ﹤0.01% |
430,600
-462,000
| -52% | -$2.08M |
|
3994
First Financial Corp
THFF
$961M
| $1.58M | ﹤0.01% |
42,806
-6,106
| -12% | -$224K |
|
3995
Eagle Bancorp
EGBN
$850M
| $1.58M | ﹤0.01% |
83,490
-15,436
| -16% | -$300K |
|
3996
Xencor
XNCR
$1.64B
| $1.57M | ﹤0.01% |
83,195
-127,610
| -61% | -$2.74M |
|
3997
iShares MSCI India Small-Cap ETF
SMIN
$774M
| $1.57M | ﹤0.01% |
19,461
-2,160
| -10% | -$163K |
|
3998
State Street SPDR S&P Capital Markets ETF
KCE
$470M
| $1.57M | ﹤0.01% |
14,227
+72
| +0.5% | +$7.88K |
|
3999
Genmab
GMAB
$19.2B
| $1.57M | ﹤0.01% |
62,408
+12,704
| +26% | +$360K |
|
4000
ReposiTrak
TRAK
$154M
| $1.57M | ﹤0.01% |
102,446
-166
| -0.2% | -$2.67K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.